Hepatitis C News and Research

RSS
Hepatitis C is a blood-borne virus that infects the liver, where it causes significant inflammation, damage and disruption of normal liver function. According to estimates by the World Health Organization, around 3 to 4 million people worldwide are infected with hepatitis C every year.

The hepatitis C virus is usually transmitted through contact with the blood of an infected individual and, most commonly, people catch it through sharing contaminated needles when injecting illegal drugs.

Hepatitis C infection is categorized into an acute and a chronic stage. The acute phase describes the first 6 months of infection when there are not necessarily any symptoms. Around one quarter of people manage to clear the infection during this stage before disease progresses to the chronic stage.

People who go on to develop chronic hepatitis C may develop jaundice which turns the skin and whites of the eyes yellow. This is caused by the build-up of a yellow-colored substance in the blood called bilirubin that would usually be broken down by the liver if it was healthy. Chronic infection may eventually cause fibrosis and scarring (cirrhosis) of the liver, liver cancer or end stage liver failure.

Hepatitis C can be treated with antiviral medications that that are designed to disrupt the multiplication of virus particles inside the body and prevent liver damage.
Scientists discover critical role of biological molecule in protecting against infection

Scientists discover critical role of biological molecule in protecting against infection

Quest Diagnostics introduces new HBV test service to help evaluate patient’s response to drug therapies

Quest Diagnostics introduces new HBV test service to help evaluate patient’s response to drug therapies

A test to evaluate Hepatitis B therapy launched by Quest Diagnostics

A test to evaluate Hepatitis B therapy launched by Quest Diagnostics

MGH-developed CTC-iChip with digital PCR assay improves detection of early-stage liver cancer

MGH-developed CTC-iChip with digital PCR assay improves detection of early-stage liver cancer

Fraunhofer scientists develop new method to irradiate pathogens using low-energy-electrons

Fraunhofer scientists develop new method to irradiate pathogens using low-energy-electrons

Georgia State University, GeoVax join forces to advance development of Hepatitis B therapeutic vaccine

Georgia State University, GeoVax join forces to advance development of Hepatitis B therapeutic vaccine

Could pathogen infection really lead to Alzheimer’s?

Could pathogen infection really lead to Alzheimer’s?

Research findings could lead to development of novel therapeutic approaches against viral infections

Research findings could lead to development of novel therapeutic approaches against viral infections

New report reveals 25% drop in overall cancer death rate in the U.S.

New report reveals 25% drop in overall cancer death rate in the U.S.

Study identifies factors linked to disengagement from treatment for opioid use disorder

Study identifies factors linked to disengagement from treatment for opioid use disorder

Study examines how ApoE gene may function differently in infectious environment

Study examines how ApoE gene may function differently in infectious environment

Scientists develop novel nanoparticle-based method to deliver DNA vaccine

Scientists develop novel nanoparticle-based method to deliver DNA vaccine

Revolutionary approach could save lives of sickest patients waiting for liver transplant

Revolutionary approach could save lives of sickest patients waiting for liver transplant

Initial rheumatoid arthritis symptoms often invisible to others, survey reveals

Initial rheumatoid arthritis symptoms often invisible to others, survey reveals

Vaxine’s unique adjuvants boost effectiveness of vaccines for battling against infectious diseases

Vaxine’s unique adjuvants boost effectiveness of vaccines for battling against infectious diseases

Type 2 diabetes linked to long list of complications that can affect health and quality of life

Type 2 diabetes linked to long list of complications that can affect health and quality of life

ECDC: 1 in 7 HIV-infected people in the EU/EEA unaware of disease status

ECDC: 1 in 7 HIV-infected people in the EU/EEA unaware of disease status

Research provides insight into molecular mechanisms involved in immune response to HBV

Research provides insight into molecular mechanisms involved in immune response to HBV

New public-private partnership launches major health effort to reduce cancer in San Francisco

New public-private partnership launches major health effort to reduce cancer in San Francisco

Molecules team up to maintain healthy level of fat in liver, study finds

Molecules team up to maintain healthy level of fat in liver, study finds